3 Quantum Computing Stocks I'd Buy Right Now

Three publicly traded pure-play quantum companies — IonQ, Rigetti and D‑Wave — are presented as diversified exposures to the nascent quantum-computing market. IonQ reported Q3 2025 revenue of $39.9M (up 222% YoY), full-year guidance of $106M–$110M and a pro‑forma cash position of ~$3.5B after a secondary, plus recent acquisitions (Vector Atomic, Oxford Ionics). Rigetti’s 84-qubit Ankaa‑3 posts a median 2‑qubit fidelity of 99.5%, has ~ $600M in cash and investments (early Nov 2025), a Fab‑1 foundry and government/commercial QPU sales, targeting 100+ qubits. D‑Wave’s Advantage2 has >4,400 annealing qubits and 133 customers, Q3 2025 revenue of $3.7M (2x YoY) and roughly $836M cash while also developing a fluxonium gate-model system. All three remain unprofitable and face scaling and competition risks, but strong revenue growth, fidelity milestones and sizable cash buffers underpin a positive risk/reward case for patient investors.

Analysis

Market structure: Trapped-ion (IONQ), superconducting modular (RGTI) and annealing (QBTS) create segmented winners — enterprise and defense buyers gain optionality, GPU incumbents (NVDA/AMD) face only gradual displacement because AI demand remains dominant near term. Expect pricing power to bifurcate: software/stack providers can earn recurring margins; hardware vendors compete on throughput, fidelity and service contracts. Cryogenics and specialized fabs tighten upstream demand (helium, low-temp components), which can lift small-cap suppliers and capex cycles in the next 12–24 months. Risk assets should see elevated correlation within tech; higher conviction in quantum could compress credit spreads for these small caps but widen implied vol in options markets.

Risk assessment: Tail risks include a technical plateau (fidelity/speed tradeoffs), accelerated M&A where big tech buys winners (e.g., MSFT/GOOG/IBM), or export controls on quantum components; any of these could move valuations +/-50% within 6–18 months. Immediate risks (days) are headline-driven volatility; short-term (3–12 months) hinge on revenue/govt contract announcements; long-term (3–5+ years) on error correction milestones and ecosystem lock-in. Hidden dependencies: foundry yield, cryogenics supply, developer tools (SDK adoption) and defense procurement cycles. Catalysts to watch: IonQ’s next fidelity publication, Rigetti’s 100+ qubit demo, D‑Wave customer deployments and Q3/Q4 revenue beats.

Trade implications: Size exposure as option-rich asymmetric bets: preferentially buy LEAP call spreads on IONQ (12–18 month expiries, target 30-delta long, sell 60-delta to fund) sizing 2–3% NAV; add 1–2% NAV in RGTI via 9–15 month call spreads tied to Fab-1 milestones; small 0.5–1% NAV in QBTS equity for immediate revenue exposure. Use pair trades: long IONQ vs short 0.5–1% NVDA call spread to hedge broad-tech drawdowns; sell short-dated covered calls (30–45 days) against positions to monetize IV and fund LEAPs. Exit/trim rules: reduce position by 50% if shares rally >60% in 90 days or if quarterly bookings miss by >15%.

Contrarian angles: Consensus overweights fidelity as sole gating factor — software APIs, partner ecosystems and recurring service revenues will likely decide winners; D‑Wave’s revenue-generating annealers and fluxonium pivot are underappreciated and may be a low-risk optionality play. The market may be underpricing consolidation risk (acquisition bids driving 30–100% premiums) and overpricing near-term commercialization; history (GPU/CUDA adoption) shows ecosystem lock-in can trump raw performance within 3–5 years. Unintended consequences include supply bottlenecks raising component costs and longer sales cycles as enterprises demand hybrid classical-quantum stacks.

Key Decisions for Investors

• Establish a 2–3% NAV long position in IONQ (IONQ) via 12–18 month LEAP call spreads (target ~30-delta long, sell 60-delta) to capture fidelity-driven optionality; fund with short 30–45 day covered calls to monetize IV. Trim 50% if shares rise >60% in 90 days or if next quarterly bookings miss guidance by >15%.
• Allocate 1–2% NAV to Rigetti (RGTI) using a 9–15 month call spread geared to Fab-1/fabrication milestones and the 100+ qubit roadmap; set a stop-loss to cut exposure by 40% if announced median 2-qubit fidelity falls >1 percentage point or contract cancellations exceed 20% of backlog.
• Hold 0.5–1% NAV in D‑Wave (QBTS) equity as a revenue hedge; buy 6–12 month protective puts (delta ~0.15) sized at 50% of the equity stake to limit downside while keeping upside to potential fluxonium breakthroughs and commercial contract cadence.
• Rebalance 3–5% from high-conviction AI GPU exposure (NVDA/AMD) into the quantum basket over 6–12 months; implement a hedged pair trade long IONQ vs short a small NVDA call spread (near-term 60–90 day) to reduce beta to the AI cycle. Monitor catalysts (IonQ fidelity paper, Rigetti 100+ qubit demo, D‑Wave customer wins) on 30–90 day cadence and reduce quantum exposure by 50% if any misses occur.